FDA says no to half doses; China, UK approve vaccines and more — 5 updates on the COVID-19 vaccine

Here are five updates on the COVID-19 vaccine from the past week:

The FDA sidelined Operation Warp Speed's idea to halve doses of Moderna's COVID-19 vaccine to expedite the vaccine rollout process, saying there is not enough data available to support this measure.

Moderna increased the minimum number of COVID-19 vaccines it expects to produce in 2021 by 20 percent to 600 million, the drugmaker said Jan. 4.

The U.S. likely won't authorize AstraZeneca's COVID-19 vaccine for emergency use until April, Operation Warp Speed Chief Moncef Slaoui, PhD, said in a Politico report.

China granted authorization to Sinopharm's COVID-19 vaccine Dec. 31, approving its first state-developed COVID-19 vaccine for use in the general public.

The United Kingdom became the first country to grant emergency use authorization for the COVID-19 vaccine developed by AstraZeneca and the University of Oxford.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast